Filter By Industry
Filter By Tag


FABPulous BV Press releases

1 - 3 of 3 Press Releases

Jul 20, 2015
The European Union awarded FABPulous BV a euro 1.6 million Phase 2 Grant to fund two clinical trials in the UK and Belgium/Netherlands and automate the manufacture of its 5-minute, patented H-FABP True Rapid Test®, which helps emergency medical workers...

Jun 29, 2015
Following successful completion of the €2.2m Series B funding round, FABPulous BV reorganizes roles within an enlarged management team to meet the challenges of evolution from R&D start up to a commercial enterprise.

Feb 04, 2015
The funds will allow the commercialization of the patented and CE-marked H-FABP True Rapid Test® for exclusion of acute myocardial infarction (AMI) in risk stratification of patients at primary care and emergency medicine.

FABPulous BV RSS Feed